更正：胡，W.等人。米氮平靶向多巴胺受体D2抑制子宫浆液性癌恶性表型。2020年，，2436。
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. 2020, , 2436.
作者信息
Hu Wen, Zhang Li, Ferri-Borgogno Sammy, Kwan Suet-Ying, Lewis Kelsey E, Cun Han T, Yeung Tsz-Lun, Soliman Pamela T, Tarapore Rohinton S, Allen Joshua E, Guan Xinyuan, Lu Karen H, Mok Samuel C, Au-Yeung Chi-Lam
机构信息
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
State Key Laboratory of Oncology in South China and Collaborative Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.
出版信息
Cancers (Basel). 2021 Feb 4;13(4):623. doi: 10.3390/cancers13040623.
Abstract
In the original article, there was a mistake in Figure 2B as published [...].
摘要
在原文中，发表的图2B存在一处错误[……]。
相似文献
1
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. 2020, , 2436.更正：胡，W.等人。米氮平靶向多巴胺受体D2抑制子宫浆液性癌恶性表型。2020年，，2436。
Cancers (Basel). 2021 Feb 4;13(4):623. doi: 10.3390/cancers13040623.
2
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype.米氮平靶向多巴胺受体D2可抑制子宫浆液性癌的恶性表型。
Cancers (Basel). 2020 Aug 27;12(9):2436. doi: 10.3390/cancers12092436.
3
Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.撤回声明：脊髓胶质细胞中的CXCL12/CXCR4趋化因子信号通过丝裂原活化蛋白激酶介导的神经炎症诱导骨癌大鼠疼痛超敏反应。
J Neurochem. 2017 May;141(3):473-474. doi: 10.1111/jnc.13949. Epub 2017 Mar 6.
4
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. 2020, , 3419.更正：杜埃尼亚斯等人。评估林奇综合征患者结肠和妇科降低风险手术的有效性。2020年，，3419。 （注：原文中两个逗号位置有些奇怪，可能存在信息不完整情况，但按要求准确翻译如上）
Cancers (Basel). 2021 Jun 22;13(13):3104. doi: 10.3390/cancers13133104.
5
Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. 2020, , 1317.更正：杜塔等人。PARP1对CCL2的转录调控是乳腺癌侵袭性的驱动因素。2020年，，1317。 （注：原文中“2020, , 1317”表述似乎不完整或有误）
Cancers (Basel). 2023 Dec 19;16(1):7. doi: 10.3390/cancers16010007.
6
Correction: W.C. Mak, et al. Controlled Delivery of Human Cells by Temperature Responsive Microcapsules. J. Funct. Biomater. 2015, 6, 439-453.更正：W.C. 麦等。温度响应性微胶囊对人类细胞的可控递送。《功能生物材料杂志》。2015年，6卷，439 - 453页。
J Funct Biomater. 2018 Mar 21;9(2):26. doi: 10.3390/jfb9020026.
7
Correction: Endrizzi et al. Relationships between Intensity and Liking for Chemosensory Stimuli in Food Models: A Large-Scale Consumer Segmentation. 2022, , 5.更正：恩德里齐等人。食品模型中化学感官刺激的强度与喜好之间的关系：大规模消费者细分。2022年，，5。
Foods. 2022 Jul 22;11(15):2174. doi: 10.3390/foods11152174.
8
Correction: Carmo et al. Effects of the Incorporation of Distinct Cations in Titanate Nanotubes on the Catalytic Activity in NO Conversion. 2021, , 2181.更正：卡尔莫等人。钛酸盐纳米管中不同阳离子的掺入对NO转化催化活性的影响。2021年，，2181。
Materials (Basel). 2022 Feb 15;15(4):1423. doi: 10.3390/ma15041423.
9
Molecular neurobiology of dopaminergic receptors.多巴胺能受体的分子神经生物学
Int Rev Neurobiol. 1993;35:391-415. doi: 10.1016/s0074-7742(08)60573-5.
10
Publisher Correction: Evolution of human malaria.出版商更正：人类疟疾的演变
Nat Microbiol. 2018 Oct;3(10):1188. doi: 10.1038/s41564-018-0249-9.
本文引用的文献
1
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype.米氮平靶向多巴胺受体D2可抑制子宫浆液性癌的恶性表型。
Cancers (Basel). 2020 Aug 27;12(9):2436. doi: 10.3390/cancers12092436.
Zotero 插件